Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03275870).
- Hydroxychloroquine in Untreated B-CLL Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine in Untreated B-CLL Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00771056).
- Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04318444).
- Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HylenexIndependent statistical analysis of Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hyp-hOPIndependent statistical analysis of Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HYPEIndependent statistical analysis of Avoidance of Hyperglycaemia in People With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04732780).
- Hyperbaric Oxygen and Outcome After Below Knee Amputations: Complete Statistical AnalysisIndependent statistical analysis of Hyperbaric Oxygen and Outcome After Below Knee Amputations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04717557).
- Hyperbaric Oxygen for COVID-19 Patients: Complete Statistical AnalysisIndependent statistical analysis of Hyperbaric Oxygen for COVID-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04332081).
- Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk: Complete Statistical AnalysisIndependent statistical analysis of Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HYPERIONIndependent statistical analysis of Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HyperlinkIndependent statistical analysis of Home Blood Pressure Telemonitoring and Case Management to Control Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00781365).
- HYPEROXIA Responses and ROS: Complete Statistical AnalysisIndependent statistical analysis of HYPEROXIA Responses and ROS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05958303).
- hyperPOCIndependent statistical analysis of Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Hyperthermic Yoga for Depressive Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Hyperthermic Yoga for Depressive Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02607514).
- Hypertonic Resuscitation Following Traumatic Injury: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Resuscitation Following Traumatic Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00316017).
- Hypertonic Saline for Acute Bronchiolitis: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Saline for Acute Bronchiolitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01247064).
- Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- HypoANSIndependent statistical analysis of Hypoglycemia and Autonomic Nervous System Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01816893).
- Hypofractionated IMRT With Temozolomide for HGG: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated IMRT With Temozolomide for HGG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082119).
- Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: primary endpoint results, effect estimate with confidence…
- HypoResusIndependent statistical analysis of Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR): Complete Statistical AnalysisIndependent statistical analysis of Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hypothyroidism Treated With Calcitonin: Complete Statistical AnalysisIndependent statistical analysis of Hypothyroidism Treated With Calcitonin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03342001).
- Hypoxic Pulmonary Vasoconstriction Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hypoxic Pulmonary Vasoconstriction Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03733470).
- HYROSIndependent statistical analysis of HYbrid RObotic Surgery in Urology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05864040).
- Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata: Complete Statistical AnalysisIndependent statistical analysis of Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00731341).
- Hysteroscopic Lymphatic Mapping for Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hysteroscopic Lymphatic Mapping for Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00671606).
- I-CAREIndependent statistical analysis of Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03119259).
- I-D-HEALTHIndependent statistical analysis of Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- I-gelIndependent statistical analysis of Comparison of I-gel to the Laryngeal Mask Airway: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00706823).
- I-KANIndependent statistical analysis of The I-KAN Study: Internet Insulin Education for Kansans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01408628).
- i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management: Complete Statistical AnalysisIndependent statistical analysis of i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- I-SCREENIndependent statistical analysis of Increasing Screening for Cancer Using EHR-Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06177795).
- I-STAND R21: Reducing Sedentary Time in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of I-STAND R21: Reducing Sedentary Time in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02692560).
- I2PETHVIndependent statistical analysis of I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02323217).
- iAIM EDUIndependent statistical analysis of Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IASISIndependent statistical analysis of Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IATCIIndependent statistical analysis of IV Iron for the Anemia of Traumatic Critical Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180894).
- iATTENDIndependent statistical analysis of The Improving ATTENDance to Cardiac Rehabilitation Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03646760).
- IBPSIndependent statistical analysis of Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03303391).
- Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05399641).
- Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00493454).